BC PARTNERS invests in InfoRLife

The investment vehicle BC Partners Fund XII acquires a minority co-control stake of approximately 50% in the company InfoRLife. The shares are divested by Sergio Dusci, the current Chief Executive Officer of the target, alongside the founding families of the Italian pharmaceutical group ACS Dobfar. Following the completion of this transaction, the historical sellers maintain their equity presence by retaining strict ownership of the remaining stake. The financial structure allocates new liquidity to fund research and development activities, expand the physical product pipeline, and execute future external growth operations within the medical market. The legal engineering for the acquirer is structured by the law firm Latham & Watkins, with a team led by partners Stefano Sciolla and Andrea Stincardini, supported by Giuseppe Liotine on antitrust matters and Cesare Milani for regulatory profiles. For the Swiss jurisdiction, the law firm Bär & Karrer deploys a team led by Susanne Schreiber, Paolo Bottini, and Andrea Ziswiler to handle the legal and tax aspects of the purchase. The tax structuring for BC Partners is overseen by the firm Facchini Rossi Michelutti under the supervision of Luca Rossi and Marina Ampolilla. In terms of audit and financial advisory, the acquirer mandates the institutions Jefferies, Rothschild, and PwC. On the sellers' side, the law firm LCA drafts the contractual documentation under the direction of Daniele Bonvicini and Matteo Montironi. The specificities related to Swiss corporate law are managed by the law firm MLL with Sergio Bortolani and Samuele Celio. The entity Tremonti Partners audits the Italian tax profiles of the sellers under the direction of Antonio Vitali. The firm Alira Health acts as the exclusive financial and commercial advisor on behalf of ACS Dobfar and Sergio Dusci throughout the structural process.